Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
Gynecologic cancer |
| gptkbp:affects |
gptkb:Uterus
Endometrium |
| gptkbp:associatedWith |
PTEN mutation
MLH1 mutation MSH2 mutation P53 mutation |
| gptkbp:canMetastasizeTo |
gptkb:bone
Lungs Liver Lymph nodes |
| gptkbp:commonIn |
Postmenopausal women
|
| gptkbp:diagnosedBy |
Dilation and curettage
Endometrial biopsy Transvaginal ultrasound |
| gptkbp:firstDescribed |
19th century
|
| gptkbp:hasScreening |
No standard screening
|
| https://www.w3.org/2000/01/rdf-schema#label |
Endometrial carcinoma
|
| gptkbp:ICD-10_code |
gptkb:C54.1
|
| gptkbp:incidence |
Most common gynecologic malignancy in developed countries
|
| gptkbp:marking |
CA-125 (sometimes elevated)
|
| gptkbp:predecessor |
Endometrial hyperplasia
|
| gptkbp:prevalence |
More common in developed countries
|
| gptkbp:prognosis |
Good if detected early
|
| gptkbp:riskFactor |
gptkb:Lynch_syndrome
gptkb:Diabetes_mellitus gptkb:Polycystic_ovary_syndrome Obesity Hypertension Early menarche Late menopause Nulliparity Tamoxifen use Unopposed estrogen exposure |
| gptkbp:stageName |
gptkb:FIGO_staging
|
| gptkbp:subspecies |
gptkb:Clear_cell_carcinoma
gptkb:Endometrioid_adenocarcinoma gptkb:Serous_carcinoma |
| gptkbp:symptom |
Weight loss
Abnormal uterine bleeding Pelvic pain Postmenopausal bleeding |
| gptkbp:treatment |
radiation therapy
Surgery Chemotherapy Hysterectomy Hormonal therapy |
| gptkbp:bfsParent |
gptkb:Uterine_cancer
|
| gptkbp:bfsLayer |
7
|